New Amsterdam Pharma
Signal active
Organization
Contact Information
Overview
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
About
Industries
Biotechnology, Life Science, Pharmaceutical
Founded
2019
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
New Amsterdam Pharma headquartered in Europe, operates in the Biotechnology, Life Science, Pharmaceutical sector. The company focuses on Biotechnology and has secured $47.2B in funding across 60 round(s). With a team of 11-50 employees, New Amsterdam Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - New Amsterdam Pharma, raised $175.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$786.3M
Details
1
New Amsterdam Pharma has raised a total of $786.3M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 194.4M |
Investors
New Amsterdam Pharma is funded by 27 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| LSP Dementia Fund | - | FUNDING ROUND - LSP Dementia Fund | 235.0M |
| Frazier Healthcare Partners | - | FUNDING ROUND - Frazier Healthcare Partners | 235.0M |
| New Amsterdam Pharma | - | FUNDING ROUND - New Amsterdam Pharma | 235.0M |
| RA Capital Management | - | FUNDING ROUND - RA Capital Management | 235.0M |
Recent Activity
There is no recent news or activity for this profile.